Lyra Therapeutics
LYRA
$0.38
Share price
4.19%
Change (1 day)
-86.02%
Change (1 year)
Categories
Lyra Therapeutics (LYRA) - Cash on Hand
Cash on Hand as of December 2023 : $0.10 B
According to Lyra Therapeutics's latest financial reports the company has $0.10 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Lyra Therapeutics - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $97.89 M | 113.99% |
| 2021-12-31 | $45.74 M | -38.67% |
| 2020-12-31 | $74.59 M | 660.53% |
| 2019-12-31 | $9.8 M | -58.94% |
| 2018-12-31 | $23.88 M |